2 Followers on Owler
OverviewCompetitorsFundingNews & Insights

Emtora Biosciences Competitors or Alternatives

Emtora Biosciences's top competitors include NexImmune, Centrose and CPP.

Unlock 22 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Emtora Biosciences's company profile

Dan Hargrov

Interim-CEO

85/100
1 - 25
$23.8M
$5M - 25M
  • $23.8M
    $5M - 25M
  • 1 - 25
    $23.8M
  • $5M - 25M
  • 85/100
  • 1 - 25
  • $23.8M
  • $5M - 25M
View ProfileView
1
Emtora Biosciences's Competitor - NexImmune logo

Kristi Jones

CEO

86/100
6
$166.4M
  • $166.4M
  • 6
    $166.4M
  • 86/100
  • 6
  • $166.4M
View ProfileView
2
Emtora Biosciences's Competitor - Centrose logo

James R. Prudent

President & CEO

90/100
1 - 25
$4.7M
$5M - 25M
  • $4.7M
    $5M - 25M
  • 1 - 25
    $4.7M
  • $5M - 25M
  • 90/100
  • 1 - 25
  • $4.7M
  • $5M - 25M
View ProfileView
3
Emtora Biosciences's Competitor - CPP logo

Jeffrey Jacob

Chairman & CEO

90/100
1 - 25
$18.2M
$100K - 5M
  • $18.2M
    $100K - 5M
  • 1 - 25
    $18.2M
  • $100K - 5M
  • 90/100
  • 1 - 25
  • $18.2M
  • $100K - 5M
View ProfileView
4
Emtora Biosciences's Competitor - Perthera logo

Donna Tuths

President & CEO

82/100
25 - 100
$17.9M
$100K - 5M
  • $17.9M
    $100K - 5M
  • 25 - 100
    $17.9M
  • $100K - 5M
  • 82/100
  • 25 - 100
  • $17.9M
  • $100K - 5M
View ProfileView
5
Emtora Biosciences's Competitor - Aura logo

Elisabet De Los Pinos

Founder & CEO

84/100
50
$452M
  • $452M
  • 50
    $452M
  • 84/100
  • 50
  • $452M
View ProfileView
Emtora Biosciences' top 25 competitors are NexImmune, Centrose, CPP, Juno Therapeutics, Perthera, Aura, bluebird bio, KinDex Therapeutics, Immetas, Mustang Bio, AVEO, Bristol-Myers Squibb, Adaptimmune, Novartis, Fate Therapeutics, Elstar Therapeutics, StemSynergy Therapeutics, Gilead, Cedilla, Castle Biosciences, Apexigen, Jounce, Oncodrone, Trusted Tablets and NantCell. Together they have raised over 37.2B between their estimated 131.3K employees. Emtora Biosciences's revenue is the ranked 15th among it's top 10 competitors. The top 10 competitors average 5.6B. Emtora Biosciences has 15 employees and is ranked 19th among it's top 10 competitors. The top 10 competitors average 5,050.

Emtora Biosciences VS NexImmune

NexImmune is one of Emtora Biosciences's top competitors. NexImmune was founded in 2011, and its headquarters is in Gaithersburg, Maryland. Like Emtora Biosciences, NexImmune also works within the Biotechnology sector. NexImmune has 9 fewer employees than Emtora Biosciences.

Emtora Biosciences VS Centrose

Centrose is Emtora Biosciences's #2 rival. Centrose was founded in 2007 in Middleton, Wisconsin. Centrose operates in the Biotechnology industry. Centrose generates $300K less revenue than Emtora Biosciences.

Emtora Biosciences VS CPP

CPP is a top competitor of Emtora Biosciences. CPP is a Private company that was founded in Tucson, Arizona in 2008. CPP is in the Biotechnology field.

Looking for similar companies to Emtora Biosciences?

Similar Companies

Pharmaceuticals companies in San Antonio

See 22 companies 
Biotechnology companies in San Antonio

See 32 companies 
Pharmaceuticals companies in Greater San Antonio

See 31 companies 
Biotechnology companies in Greater San Antonio

See 40 companies 
Pharmaceuticals & Biotechnology companies in San Antonio

See 55 companies 
Pharmaceuticals & Biotechnology companies in Greater San Antonio

See 70 companies 
Pharmaceuticals companies in Texas

See 460 companies 
Biotechnology companies in Texas

See 581 companies 
Pharmaceuticals & Biotechnology companies in Texas

See 945 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Emtora Biosciences and Emtora Biosciences's Competitors

April 16, 2025Pharmabiz
Bristol Myers Squibb announced the phase 3 ODYSSEY─HCM trial evaluating Camzyos (mavacamten) for the treatment of adult patients with symptomatic New Y...
April 15, 2025Powder and Bulk Solids
The plan is to expand US manufacturing and R&D presence with investment in 10 facilities, including 7 brand new facilities....
April 15, 2025Zacks
The FDA bestows a Regenerative Medicine Advanced Therapy tag on FATE's pipeline candidate, FT819, for treating moderate-to-severe systemic lupus erythe...
April 15, 2025Nasdaq
(RTTNews) - Bristol Myers Squibb (BMY) announced that the Phase 3 ODYSSEY-HCM trial, which evaluated Camzyos or mavacamten for the treatment of adult p...
April 15, 2025Benzinga
Bristol Myers' Camzyos missed goals in a Phase 3 nHCM trial, showing no significant benefits over placebo but raised no new safety concerns. read more...
April 16, 2025EMEA STARTUPS
Sofinnova Partners ("Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, today announced the final cl...
April 15, 2025Clinical Trials Arena
BMS could soon face competition in the HCM space as Cytokinetics awaits a marketing application decision from the FDA for aficamten. The post BMS' Camz...
Today 6:18 AMOpenpr
Global digital dose inhaler market is estimated to be valued at USD 21.96 Bn in 2025 and is expected to reach USD 77.82 Bn by 2032, exhibiting a compou...

Frequently Asked Questions about Emtora Biosciences

  1. Who are Emtora Biosciences's top competitors?

    Emtora Biosciences's top 3 competitors are NexImmune, Centrose, CPP.

  2. Who is similar to Emtora Biosciences?

    NexImmune is the most similar to Emtora Biosciences. Centrose and CPP are also similar to Emtora Biosciences.

  1. Are Emtora Biosciences and NexImmune competitors?

    Yes, NexImmune is one of Emtora Biosciences’s top competitors.